Companies /Healthcare

Avantor Inc

NYSE: AVTR Medical Instruments & Supplies
$15.72
▲ $0.17 (+1.09%) today
Markets closed · 4:56pm ET

24/7 Wall St. View

Price Prediction $17.33 +11.5% Our analysts’ 12-month view: target, optimistic case, and floor. AVTR price prediction →

AVTR at a Glance

Valuation
Market cap
$10.5B
Profitability
Revenue (TTM)
$6.6B
Profit margin
-8.8%
EPS (TTM)
$-0.84
Price
52-week range
$7 – $16
24/7 target
$17.33
Street target
$15.11
Earnings
Next report
Oct 28, 2026

Headquartered in Radnor, PA Fiscal year ends December NYSE: AVTR avantorsciences.com

About Avantor

Avantor, Inc. (NYSE: AVTR) is a global provider of mission-critical products and services to the life sciences and advanced technology industries. The company operates through two segments: VWR Distribution & Services, which distributes laboratory and production supplies, chemicals, equipment, and related services; and Bioscience & Medtech Products, which manufactures proprietary materials, reagents, and consumables used in research, pharmaceutical production, and medical device manufacturing. Avantor's portfolio spans virtually every stage of research, development, and production, serving more than 300,000 customer locations across 180 countries. The company is focused on its Revival program to improve customer experience and operational performance while actively deleveraging its balance sheet. Updated

AVTR Coverage

Frequently Asked Questions

What does Avantor do?

Avantor, Inc. (NYSE: AVTR) is a global provider of mission-critical products and services to the life sciences and advanced technology industries.

What is the AVTR stock price target?

24/7 Wall St.'s 12-month price target for AVTR is $17.33, rated Buy. The Wall Street consensus target is $15.11. AVTR price prediction →